ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $18,000 | -18.2% | 12,162 | -20.8% | 0.00% | – |
Q4 2016 | $22,000 | -21.4% | 15,349 | -5.4% | 0.00% | – |
Q3 2016 | $28,000 | 0.0% | 16,226 | 0.0% | 0.00% | – |
Q2 2016 | $28,000 | -12.5% | 16,226 | -1.0% | 0.00% | – |
Q1 2016 | $32,000 | -3.0% | 16,397 | -4.7% | 0.00% | – |
Q4 2015 | $33,000 | -2.9% | 17,208 | -3.9% | 0.00% | – |
Q3 2015 | $34,000 | -59.0% | 17,902 | 0.0% | 0.00% | – |
Q2 2015 | $83,000 | +1.2% | 17,902 | -4.2% | 0.00% | – |
Q1 2015 | $82,000 | +39.0% | 18,682 | +9.7% | 0.00% | – |
Q4 2014 | $59,000 | -20.3% | 17,036 | -3.9% | 0.00% | – |
Q3 2014 | $74,000 | -28.8% | 17,719 | 0.0% | 0.00% | -100.0% |
Q2 2014 | $104,000 | -8.8% | 17,719 | -2.4% | 0.00% | 0.0% |
Q1 2014 | $114,000 | +7.5% | 18,149 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $106,000 | +17.8% | 18,149 | +7.0% | 0.00% | 0.0% |
Q3 2013 | $90,000 | -87.7% | 16,966 | -82.1% | 0.00% | -80.0% |
Q2 2013 | $729,000 | – | 94,689 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 7,500,000 | $34,800,000 | 2.37% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,983,710 | $32,404,000 | 1.08% |
DAFNA Capital Management LLC | 189,000 | $877,000 | 0.74% |
Lyons Wealth Management, LLC. | 56,665 | $264,000 | 0.30% |
Telemetry Investments, L.L.C. | 110,000 | $510,000 | 0.23% |
Callan Capital, LLC | 232,000 | $1,076,000 | 0.23% |
OXFORD ASSET MANAGEMENT LLP | 968,446 | $4,494,000 | 0.12% |
FEDERATED HERMES, INC. | 5,641,200 | $26,175,000 | 0.08% |
HRT FINANCIAL LP | 31,973 | $148,000 | 0.07% |
WELLINGTON MANAGEMENT GROUP LLP | 33,885,551 | $157,230,000 | 0.04% |